下一代APOBEC3抑制剂:为性和核酶稳定性进行最佳设计
Adam K Hedger1,2, Wazo Myint3, Jeong Min Lee1
1Department of Biochemistry and Molecular Biotechnology, UMass Chan Medical School, Worcester, MA 01605, United States.
Nucleic acids research
|March 29, 2025
概括
研究人员开发出强大的寡核酸抑制剂,向APOBEC3酶 (A3A和A3G),这对癌症和病毒耐药性至关重要. 这些改性DNA抑制剂显示出增强的稳定性和有效性,为新的A3向疗法铺平了道路.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- APOBEC3 (A3) 酶有助于病毒和癌症的异质性,经常导致药物耐药性.
- 目前针对A3酶的寡核酸抑制剂缺乏细胞稳定性和功效.
- 开发有效的A3抑制剂对于治疗应用至关重要.
研究的目的:
- 为了增强针对A3A和A3G酶的寡核酸抑制剂的功效和核酶稳定性.
- 为A3介导疾病创造具有改善治疗潜力的新型抑制剂.
- 为了克服现有的基 (PO) 结合的DNA基抑制剂的局限性.
主要方法:
- 修改基于2'-脱氧泽布林 (dZ) 基质的寡核酸抑制剂.
- 纳入酸 (PS) 链接和混合PO/PS骨干.
- 引入2'-糖修饰和锁定核酸 (LNA) 糖修饰.
- 发针结构抑制剂的设计,具有优化的PS模式.
主要成果:
- 混合PO/PS骨干显著增强了抑制剂效力 (高达9倍) 和核酶耐药性.
- 开发了第一个使用2'-改性的A3G-CTD2纳米抑制剂.
- 描述了A3A的第一个单位纳米分子抑制剂,使用头结构,优化PS和LNA修改.
- 证明强大的A3A抑制剂限制了纤维素中的A3A去胺,并且具有高度的核酶耐药性.
结论:
- 最佳设计的A3寡核酸抑制剂与以前的药物相比,具有更高的效力和稳定性.
- 这些增强抑制剂代表了实现A3抑制的治疗潜力的重大进展.
- 开发的抑制剂为针对病毒感染和癌症治疗中的A3酶提供了一个有希望的策略.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...


